A beneficial role of cardiac P2X4 receptors in heart failure: rescue of the calsequestrin overexpression model of cardiomyopathy
- 1 September 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (3), H1096-H1103
- https://doi.org/10.1152/ajpheart.00079.2004
Abstract
The P2X4 purinergic receptor (P2X4R) is a ligand-gated ion channel. Its activation by extracellular ATP results in Ca2+ influx. Transgenic cardiac overexpression of the human P2X4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, we tested the hypothesis that this receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X4R mouse, n = 35) of the CSQ mouse (71.3 ± 25.4 days, n = 50, P < 0.0001). The prolonged survival in the binary CSQ/P2X4R mouse was associated with an improved left ventricular weight-to-body weight ratio and a restored β-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but correlated with improved left ventricular developed pressure and ±dP/d t. The enhanced cardiac performance was manifested in young binary animals and persisted in older animals. The increased contractility likely underlies the survival benefit from P2X4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.Keywords
This publication has 22 references indexed in Scilit:
- P2X4 Receptor Is a Glycosylated Cardiac Receptor Mediating a Positive Inotropic Response to ATPPublished by Elsevier ,2002
- A novel contractile phenotype with cardiac transgenic expression of the human P2X 4 receptorThe FASEB Journal, 2001
- Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failureProceedings of the National Academy of Sciences, 2001
- A method to produce Ponceau replicas from blots: Application for Western analysisElectrophoresis, 2000
- Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin OverexpressionPublished by Elsevier ,1999
- Towards a revised nomenclature for P1 and P2 receptorsTrends in Pharmacological Sciences, 1997
- Actin cytoskeleton: Setting the pace of cell movementCurrent Biology, 1995
- Mechanism of extracellular ATP‐induced increase of cytosolic Ca2+ concentration in isolated rat ventricular myocytes.The Journal of Physiology, 1992
- ATP receptor-induced Ca2+ transients in cardiac myocytes: sources of mobilized Ca2+American Journal of Physiology-Cell Physiology, 1989
- Extracellular ATP has a potent effect to enhance cystolic calcium and contractility in single ventricular myocytesCell Calcium, 1988